TYCUS deidentified NEJM clean in The Impact of Early Medical Treatment on Transgender Youth- Gender Affirming Hormone Cohort

Dataset of selected variables from Baseline through 24month study visits
Study Description
The study used a longitudinal observational design to examine the outcomes of existing medical treatment protocols for gender dysphoria in youth pursuing a phenotypic gender change through gender affirming hormones. Routinely collected anthropometric and physiologic parameters were collected through chart abstraction throughout the 9-year study period. Research Electronic Data Capture (REDCap), ASEBA, and individual interview survey instruments were used to collect demographic, mental health, psychosocial, and behavioral data from youth in the gender-affirming hormone cohort at baseline and 6, 12, 18 months, and every year for 2-9 years. Participants are recruited from those patients seeking medical care for gender dysphoria at any of the four study sites.